Fermi founder calls shareholder meeting amid strategic review push

Fermi Inc. called a special shareholder meeting for May 29, 2026, where Toby Neugebauer will nominate five directors and seek shareholder input on the company’s direction, including potential strategic transactions. The stock has fallen to $5.07, down 84% from a 52-week high of $36.99, while the company also faces $603 million in negative free cash flow over the last twelve months. The proxy fight and leadership changes add governance uncertainty ahead of earnings on May 14.

Analysis

The market is treating this as a governance event, but the bigger signal is balance-sheet control. When a founder with a large economic stake tries to reset the board amid a steep drawdown and looming earnings, the hidden catalyst is usually either a financing reset or a forced strategic review; both can re-rate the equity quickly if they improve credibility, but they can also expose how fragile the capital structure really is. The current setup favors volatility over direction: bad news can gap the stock lower on any dilution/going-concern language, while even a modestly constructive plan could trigger a sharp squeeze because ownership is concentrated and float dynamics are tight.

Second-order effects matter more than the headline. A director fight plus an M&A narrative often pulls in advisors, creates information leakage, and raises the probability that the company becomes a process story rather than an execution story over the next 4-12 weeks. That typically benefits event-driven and distressed-specialist funds, while punishing passive holders and any shorts that are leaning on weak momentum without hard borrow protection. The operating angle is that every delay in project milestones increases the discount rate applied to long-dated assets, so the market may be underestimating how much the core value depends on uninterrupted access to capital between now and the special meeting.

The contrarian case is that the selloff may already reflect the obvious governance overhang, so the better short is not the stock outright but the financing path. If management secures a credible strategic partner or asset sale framework before or right after earnings, the equity could reprice violently higher from deeply depressed levels, especially if the proxy fight consolidates insider support. Conversely, if earnings show accelerating cash burn without a matching funding bridge, the equity can transition from a governance trade into a solvency trade almost overnight.

Key Decisions for Investors

• FRMI: Buy short-dated straddles into earnings/special-meeting window (May 14 to May 29) to own the governance-volatility event; this is a cleaner expression than directionally guessing board outcome.
• FRMI: If borrow is available and cost is reasonable, initiate a tactical short only on any post-earnings spike above the pre-meeting range; cover quickly into the proxy filing if strategic transaction language turns concrete.
• FRMI: Consider a pair trade long FRMI / short a lower-beta data-center infrastructure peer only if you believe an M&A process is imminent; otherwise avoid relative-value because FRMI’s outcome is dominated by financing/governance, not sector beta.
• FRMI: For risk-controlled bullish exposure, wait for definitive proxy details and only then buy call spreads; upside is asymmetric if a credible sale or recap emerges, but downside remains open-ended on dilution risk.
• UBS: No direct single-name trade from this note, but keep on the radar as a sentiment check on financing/IPO-adjacent infrastructure names; tighter capital markets can spill over to underwritten growth stories in the same ecosystem.